Article Information
History
- August 11, 2021.
Article Versions
- Version 1 (August 10, 2021 - 12:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bavithra Vijayakumar1,2,3,+,
- Karim Boustani1,4,+,
- Patricia P. Ogger1,+,
- Artermis Papadaki5,+,
- James Tonkin1,3,
- Christopher M. Orton1,3,
- Poonam Ghai1,
- Kornelija Suveizdyte1,
- Richard J. Hewitt1,3,
- Robert J. Snelgrove1,4,
- Philip L. Molyneaux1,3,
- Justin L. Garner2,3,
- James E. Peters5,*,
- Pallav L. Shah1,2,3,*,
- Clare M. Lloyd1,4,* and
- James A. Harker1,4,*,#
- 1National Heart and Lung Institute, Imperial College London, London, UK
- 2Chelsea and Westminster Hospital, London, UK
- 3Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- 4Asthma UK Centre for Allergic Mechanisms of Asthma
- 5Centre for Inflammatory Disease, Dept of Immunology and Inflammation, Imperial College London, Hammersmith Hospital, London, UK
- ↵#Lead contact: Dr James A Harker, j.harker{at}imperial.ac.uk, Sir Alexander Fleming Building, National Heart and Lung Institute, South Kensington Campus, Imperial College London, London, UK. SW7 2AZ.
Posted August 11, 2021.
Immuno-proteomic profiling reveals abundant airway CD8 T cells and ongoing epithelial injury in prolonged post-COVID19 respiratory disease
